The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of african-americans

Journal of the American Geriatrics Society

Volumn 48, Issue 9, 2000, Pages 1035-1041

  Richards, Stephanie S ^a   Emsley, Christine L ^b   Roberts, John ^b   Murray, Michael D ^b   Hall, Kathleen ^b   Gao, Sujuan ^a   Hendrie, Hugh C ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

African American; Antihypertensive medication; Cognitive impairment; Dementia; Vascular risk

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ARTICLE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; PREVALENCE; RISK ASSESSMENT;

EID: 0033858389     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2000.tb04777.x     Document Type: Article

References (47)

1. Vascular dementia redefined
2. Epidemiology of dementia and Alzheimer disease
3. Brain infarction and the clinical expression of Alzheimer's disease: The Nun Study
4. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease The CERAD experience
5. Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer's disease
6. Essential hypertension and cognitive function: The role of hyperinsulinemia
7. Relationship of free-recall memory to hypertension in the elderly: The Iowa 65+ Rural Health Study
8. Blood pressure and cognitive function in healthy old people
9. Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: The Framingham Study
10. Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study
11. Blood pressure, hypertension, and age as risk factors for poor cognitive performance
12. Hypertension is related to cognitive impairment: A 20-year follow-up of 999 men
13. Blood pressure and performance on the Mini Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Proiect
14. The association between midlife blood pressure levels and late-life cognitive function: The Honolulu-Asia Aging Study
15. 15-year longitudinal study of blood pressure and dementia
16. Psychometric evaluation of performance in diabetes mellitus
17. Decreased cognitive function in aging non-insulin-dependent diabetic patients
18. Age and diabetes related changes in verbal fluency
19. Cortical function in elderly non-insulin dependent diabetic patients. Behavioral and electrophysiologic studies
20. The mental efficiency of the elderly person with type II diabetes mellitus
21. Relationship between hyperglycemia and cognitive function in older NIDDM patients
22. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men
23. Triglyceride levels affect cognitive function in noninsulin-dependent diabetics
24. Plasma lipids and geriatric assessment in a very aged population in south Italy
25. The development of a dementia screening interview in two distinct languages
26. A cross-cultural community based study of dementias: Methods and performance of the survey instrument, Indianapolis, U.S.A., and Ibadan, Nigeria
27. Alzheimer's Disease is rare in Cree
28. The prevalence of Alzheimer's Disease and dementia in two communities: Nigerian Africans and African Americans
29. 'Mini-Mental State:' A practical method for grading the cognitive state of patients for the clinician
30. CAMDEX: A standardized instrument for the diagnosis of mental disorders in the elderly with special reference to the early detection of dementia
31. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part I. Clinical and neuropsychological assessment of Alzheimer's disease
32. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
33. Improved cognition after control of risk factors for multi-infarct dementia
34. Treatment of hypertension in the elderly I.I. Cognitive and behavioral function. Results of a Department of Veterans Affairs cooperative study
35. The effects of antihypertensive treatment on cognitive function: Results from the HOPE study
36. Impact of treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program
37. Is the cognitive function of older patients affected by hypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults
38. Adverse drug reactions associated with global cognitive impairment in elderly persons
39. Impairment of memory function by antihypertensive medication
40. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes
41. The relationship of serum cholesterol changes to psychological abilities
42. Reducing hypertriglyceridemia in elderly patients with cerebrovascular disease stabilizes or improves cognition and cerebral perfusion
43. Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemia
44. Effects of treatment with lovastatin and pravastatin on daytime cognitive performance
45. Is there any evidence for a protective effect of antithrombotic medication on cognitive function in men at risk for cardiovascular disease? Some preliminary findings